The peroxisome proliferator-activated receptor α (PPARα):: role in hepatocarcinogenesis

被引:55
作者
Gonzalez, FJ [1 ]
机构
[1] NCI, NIH, Bethesda, MD 20892 USA
关键词
peroxisome proliferators; PPAR alpha; apoptosis; oxidative stress; hepatocarcinogenesis; Kupffer cells; cytokines;
D O I
10.1016/S0303-7207(02)00098-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The peroxisome proliferator-activated receptor alpha (PPARalpha) is a member of the nuclear receptor superfamily and mediates most of the known biological effects of peroxisome proliferators. The latter represents a large group of chemicals that include the fibrate hyperlipidemic drugs, the pthalate plasticizers, various solvents and degreasing agents, and endogenous hormones and fatty acids. Peroxisome proliferators are classical members of the nongenotoxic group of chemical carcinogens that do not require metabolic activation to electrophiles in order to exert their harmful effects. These chemicals are of particular concern to regulatory agencies since they can only be detected by long-term carcinogen bioassays using rodents. The mechanism of the carcinogenic action of peroxisome proliferators is beginning to emerge. PPARalpha-null mice are resistant to hepatocarcinogenesis indicating that this receptor is necessary for cancer. However, recent studies indicate that Kupffer cells, in a PPARalpha independent manor, are required for the major effects of peroxisome proliferators on cell proliferation. An interaction between PPARalpha and estrogen carcinogenesis has also been elucidated. (C) 2002 Published by Elsevier Science Ireland Ltd.
引用
收藏
页码:71 / 79
页数:9
相关论文
共 73 条
[41]  
LOCK EA, 1989, ANNU REV PHARMACOL, V29, P145
[42]   Apoptosis in cancer [J].
Lowe, SW ;
Lin, AW .
CARCINOGENESIS, 2000, 21 (03) :485-495
[43]   LACK OF COMITOGENICITY BY THE PEROXISOME PROLIFERATOR HEPATOCARCINOGENS, WY-14,643 AND CLOFIBRIC ACID [J].
MARSMAN, DS ;
SWANSONPFEIFFER, CL ;
POPP, JA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1993, 122 (01) :1-6
[44]   HUMAN AND RAT PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPARS) DEMONSTRATE SIMILAR TISSUE DISTRIBUTION BUT DIFFERENT RESPONSIVENESS TO PPAR ACTIVATORS [J].
MUKHERJEE, R ;
JOW, L ;
NOONAN, D ;
MCDONNELL, DP .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1994, 51 (3-4) :157-166
[45]   PPAR-γ agonists:: therapeutic role in diabetes, inflammation and cancer [J].
Murphy, GJ ;
Holder, JC .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (12) :469-474
[46]   A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport [J].
Oliver, WR ;
Shenk, JL ;
Snaith, MR ;
Russell, CS ;
Plunket, KD ;
Bodkin, NL ;
Lewis, MC ;
Winegar, DA ;
Sznaidman, ML ;
Lambert, MH ;
Xu, HE ;
Sternbach, DD ;
Kliewer, SA ;
Hansen, BC ;
Willson, TM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (09) :5306-5311
[47]   Peroxisome proliferator activated receptor-α expression in human liver [J].
Palmer, CNA ;
Hsu, MH ;
Griffin, KJ ;
Raucy, JL ;
Johnson, EF .
MOLECULAR PHARMACOLOGY, 1998, 53 (01) :14-22
[48]   Genetic disruption of PPARδ decreases the tumorigenicity of human colon cancer cells [J].
Park, BH ;
Vogelstein, B ;
Kinzler, KW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) :2598-2603
[49]   Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes [J].
Parzefall, W ;
Berger, W ;
Kainzbauer, E ;
Teufelhofer, O ;
Schulte-Hermann, R ;
Thurman, RG .
CARCINOGENESIS, 2001, 22 (03) :519-523
[50]   Peroxisome proliferator-activated receptor α is restricted to hepatic parenchymal cells, not Kupffer cells:: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis [J].
Peters, JM ;
Rusyn, I ;
Rose, ML ;
Gonzalez, FJ ;
Thurman, RG .
CARCINOGENESIS, 2000, 21 (04) :823-826